P-309 Low/intermerdiate-1 risk MDS treated with high-dose rHu-EPO: Hematological responses and impact on quality of life, a prospective GFM study.
Saved in:
| Title: | P-309 Low/intermerdiate-1 risk MDS treated with high-dose rHu-EPO: Hematological responses and impact on quality of life, a prospective GFM study. |
|---|---|
| Authors: | Tessoulin, B., Beyne-RAuzy, O., Guerci, A., Gyan, E., Hunault, M., Ianotto, J.C., Shanti, A., Stamatoullas, A., Dreyfus, F., Fenaux, P., Delaunay, J. |
| Source: | Leukemia Research. May2013 Supplement, Vol. 37, pS161-S161. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01452126 |
|---|---|
| DOI: | 10.1016/S0145-2126(13)70356-4 |
